30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Centinel Spine Reports New prodisc C Study Results -

New study results suggest strong support of the safety of the prodisc® C Cervical Total Disc Replacement from Centinel Spine.

In the study of 504 consecutive patients, investigators found no secondary surgery requirements for device failure and a low reoperation rate of 5.5%, including the learning curve for every participating surgeon. The study encompassed results, specifically reoperation rates, for all consecutive patients receiving a prodisc C over a 15-year timeframe at a single center. 

Single-center study designs eliminate many surgical and data collection variables seen in multi-center analyses, and address multi-center study weaknesses such as learning curve effects. In this study, prodisc C was the first arthroplasty device utilized by many of the surgeons. (Centinel Spine, LLC, 5/2/19)